Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Felzartamab + Dexamethasone in RRMM
NCT03860038Phase 2Completed
- Sponsor
- TJ Biopharma
- Start
- Jan 2019
- Primary completion
- Jan 2023
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of felzartamab in multiple myeloma (MM), sponsored by TJ Biopharma. Started Jan 2019; status: completed.
02
Drugs
felzartamab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03860038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03860038.